Research Article | Volume: 5, Supplement: 3, November, 2015
Research Article | Volume: 5, Supplement: 3, November, 2015
Background: In the present days, the prevalence of hypertension is potentially increasing. To overcome the effects of this disease, a complex therapeutic regimen is often introduced, but the patient compliance is always questionable. Methodology: To improve patient compliance, a novel approach has to be implemented. Hence, the present study was designed to develop a transdermal patch containing Atenolol and hydrochlorothiazide in combination using blends of different polymeric combinations such as hydroxypropyl methyl cellulose, sodium alginate, and polyethylene glycol. The patches were subjected to physicochemical tests and in-vitro drug release study. Results: Good results were obtained in all the evaluated parameters. The drug release of all formulation followed zero order kinetics. The medicated films also went through primary skin irritation test and the results showed that the films were non-irritant. Conclusion: The developed transdermal delivery system containing Atenolol & hydrochlorothiazide might be a milestone in the combinational therapy of hypertension.
Thyagarajan A, Udaya Chander JSJ, Senthil Kumar C, Sreenivasan V, Venkata Narayanan R. Preparation, In-Vitro Characterization of Transdermal Patch Containing Atenolol and Hydrochlorothiazide: A Combinational Approach. J App Pharm Sci, 2015; 5 (Suppl 3): 033-039.
Year
Month
Formulation and evaluation of transdermal patches and to study permeation enhancement effect of eugenol
Nirav S Sheth, Rajan B MistryAmlodipine-Atenolol Overdose Management: A Physician’s Nightmare
Spectrophotometric Simultaneous Determination of Hydrochlorothiazide and Telmisartan in Combined Dosage Form
Rekha Gangola, Sunil Kaushik, Paras SharmaAntidiuretic and antidiarrhoeal activities of polar and non-polar extract of Brassica oleracea